Cannabinoids and neuronal signal transmission;Cannabinoide und neurale signalübertragung

Sucht

Volumn 50, Issue 5, 2004, Pages 297-308

  Wallmichrath, Ilka ^a   Szabo, Bela ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cannabinoids; Electrophysiology; Endocannabinoids; Neurotransmission; Presynaptic inhibition

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; ENDOCANNABINOID; UNCLASSIFIED DRUG;

BRAIN SLICE; CHOLINERGIC TRANSMISSION; ELECTROPHYSIOLOGY; INHIBITION KINETICS; NERVE CELL; NERVE ENDING; NEUROTRANSMITTER RELEASE; PATCH CLAMP; PRESYNAPTIC INHIBITION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

EID: 8444232067     PISSN: 09395911     EISSN: None     Source Type: Journal    
DOI: 10.1463/2004.05.03     Document Type: Review

References (112)

1. 1 cannabinoid receptor gene. Biochemical Pharmacology, 53, 207-214.
2. Ahluwalia, J., Urban, L., Bevan, S., Capogna, M. & Nagy, I. (2002). Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurons. Neuroscience, 110, 747-753.
3. Ameri, A., Wilhelm, A. & Simmet, T. (1999). Effects of the endogenous cannabinoid, anandamide, on neuronal activity in rat hippocampus slices. British Journal of Pharmacology, 126, 1831-1839.
4. Auclair, N., Otani, S., Soubrie, P. & Crepel, F. (2000). Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. Journal of Neurophysiology, 83, 3287-3293.
5. Azad, S. C., Eder, M., Marsicano, G., Lutz, B., Zieglgänsberger, W. & Rammes, G. (2003). Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learning and Memory, 10, 116-128.
6. 3A receptors: probable involvement of an allosteric modulatory site. British Journal of Pharmacology, 137, 589-596.
7. Caulfield, M. P., Brown, D. A. (1992). Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a Pertussis toxin-sensitive mechanism. British Journal of Pharmacology, 106, 231-232.
8. Chemin, J., Monteil, A., Perez-Reyes, E., Nargeot, J. & Lory, P. (2001). Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO Journal, 20, 7033-7040.
9. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A. & Gilula, N. B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
10. 1 receptors in human ileum. British Journal of Pharmacology, 125, 1393-1395.
11. + channels. Journal of Physiology, London, 537, 793-800.
12. Deadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A. & Childers, S. (1995). Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. Journal of Pharmacology and Experimental Therapeutics, 273, 734-743.
13. Di, S., Malcher-Lopes, R., Halmos, K. C. & Tasker, J. G. (2003). Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. Journal of Neuroscience, 23, 4850-4857.
14. Diana, M. A., Levenes, C., Mackie, K. & Marty, A. (2002). Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. Journal of Neuroscience, 22, 200-208.
15. Di Marzo, V., Melck, D., Bisogno, T. & De Petrocellis, L. (1998). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends in Neurosciences, 21, 521-528.
16. Dove Pettit, D. A., Harrison, M. P., Olson, J. M., Spencer, R. F. & Cabral, G. A. (1998). Immunohistochemical localization of the neural cannabinoid receptor in rat brain. Journal of Neuroscience Research, 51, 391-402.
17. 3 receptors in rat nodose ganglion neurons. Journal of Neurophysiology, 73, 907-910.
18. 2 receptors. Molecular Pharmacology, 48, 443-450.
19. 1 cannabinoid receptor. Journal of Neuroscience, 18, 2834-2841.
20. Gerard, C. M., Mollereau, C., Vassart, G. & Parmentier, M. (1991). Molecular cloning of a human cannabinoid receptor which is also expressed in testis. The Biochemical Journal, 279, 129-134.
21. 1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. Journal of Neurophysiology, 85, 468-471.
22. Gifford, A. N. & Ashby, Jr. C. R. (1996). Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. The Journal of Pharmacology and Experimental Therapeutics, 277, 1431-1436.
23. 2 cannabinoid receptor. The Journal of Pharmacology and Experimental Therapeutics, 292, 886-894.
24. Hájos, N. & Freund, T. F. (2002). Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology, 43, 503-510.
25. 5 proteins in cultured hippocampal neurons. Journal of Neurophysiology, 84, 2356-2364.
26. 1 receptor. Proceedings of the National Academy of the United States of America, 98, 3662-3665.
27. Henry, D. J. & Chavkin, C. (1995). Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neuroscience Letters, 186, 91-94.
28. Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R. & Rice K. C. (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience, 11, 563-583.
29. Hillard, C. J. & Jarrahian, A. (2000). The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chemistry and Physics of Lipids, 108, 123-134.
30. 1). The Journal of Pharmacology and Experimental Therapeutics, 289, 1427-1433.
31. Hoffman, A. F., Lupica, C. R. (2000). Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus, Journal of Neuroscience, 20, 2470-2479.
32. Hoffman, A. F. & Lupica, C. R. (2001). Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids, Journal of Neurophysiology, 85, 72-83.
33. Hohmann, A. G. & Merkenham, M. (1999). Cannabinoid receptors undergo axonal flow in sensory nerves, Neuroscience, 92, 1171-1175.
34. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R. & Pertwee, R. G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors, Pharmacological Review, 54, 161-202.
35. Huang, C.-C., Lo, S.-W. & Hsu, K.-S. (2001a). Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. Journal of Physiology (Lond), 532, 731-748.
36. Huang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., De Petrocellis, L., Burstein, S., Di Marzo, V. & Walker, J. M. (2001b). Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. Journal of Biological Chemistry, 276, 42639-42644.
37. 1 receptors on peripheral sympathetic nerves, British Journal of Pharmacology, 118, 2023-2028.
38. 1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain, Naunyn-Schmiedeberg's Archives of Pharmacolgy, 359, 466-470.
39. 1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice, Naunyn-Schmiedeberg's Archives of Pharmacolgy, 363, 50-56.
40. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons, Journal of Neuroscience, 19, 4544-4558.
41. Katona, I., Sperlagh, B., Magloczky, Z., Santha, E., Köfalvi, A., Czirjak, S., Mackie, K., Vizi, E. S. & Freund, T. F. (2000). GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience, 100, 797-804.
42. 1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. Journal of Neuroscience, 21, 9506-9518.
43. Kreitzer, A. C. & Regehr, W. G. (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells, Neuron, 29, 717-727.
44. Kuster, J. E., Stevenson, J. I., Ward, S. J., D'Ambra, T. E. & Haycock, D. A. (1993). Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids, Journal of Pharmacology and Experimental Therapeutics, 264, 1352-1363.
45. Levenes, C., Daniel, H., Soubrie, P. & Crepel, F. (1998). Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells, Journal of Physiology (Lond), 510, 867-879.
46. Llano, I., Leresche, N. & Marty, A. (1991). Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents, Neuron, 6, 565-574.
47. Lynn, A. B. & Herkenham, M. (1994). Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids, Journal of Pharmacology and Experimental Therapeutics, 268, 1612-1623.
48. Mackie, K. & Hille, B. (1992). Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proceedings of the National Academy of Sciences of the United States of America, 89, 3825-3829.
49. Mackie, K., Devane, W. A. & Hille, B. (1993). Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N 18 neuroblastoma cells, Molecular Pharmacology, 44, 498-503.
50. Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995). Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type Calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor, Journal of Neuroscience, 15, 6552-6561.
51. Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A. & Kano, M. (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors, Neuron, 31, 463-475.
52. Mailleux, P. & Vanderhaeghen, J.-J. (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48, 655-668.
53. + channel TASK-1, The EMBO Journal, 20, 47-54.
54. 2 cannabinoid receptor agonists: pain relief without psychoactive effects?, Current Opinion in Pharmacology, 3, 62-67.
55. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat, Naunyn-Schmiedeberg's Archives of Pharmacolgy, 356, 197-202.
56. 1 receptors, Naunyn-Schmiedeberg's Archives of Pharmacolgy, 364, 233-241.
57. Manzoni, O. J. & Bockaert, J. (2001). Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens, European Journal of Pharmacology, 412, R3-R5.
58. Martin, B. R. (2002). Identification of the endogenous cannabinoid system through integrative pharmacological approaches, J. Pharmacol. Exp. Ther., 301, 790-796.
59. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. (1990). Structure of cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561-564.
60. Matsuda, L. A., Bonner, T. I. & Lolait, S. J. (1993). Localization of cannabinoid receptor mRNA in rat brain, Journal of Comparative Neurology, 327, 535-550.
61. 1 receptors. Journal of Neuroscience, 24, 53-62.
62. Misner, D. L. & Sullivan, J. M. (1999). Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons, J. Neurosci., 19, 6795-6805.
63. Morisset, V. & Urban, L. (2001). Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord, Journal of Neurophysiology, 86, 40-48.
64. Mu, J., Zhuang, S.-Y., Hampson, R. E. & Deadwyler, S. A. (2000). Protein kinase-dependent phosphorylation and cannabinoid receptor modulation of potassium A current (IA) in cultured rat hippocampal neurons, Pflügers Archiv - European Journal of Physiology, 439, 541-546.
65. Munro, S., Thomas, K. L. & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365, 61-65.
66. Nakatsuka, T., Chen, H.-X., Roper, S. N. & Gu, J. G. (2003). Cannabinoid receptor-1 activation suppresses inhibitory synaptic activity in human dentate gyrus, Neuropharmacology, 45, 116-121.
67. 1 receptors, Naunyn-Schmiedeberg's Archives of Pharmacolgy, 361, 19-24.
68. Niederhoffer, N. & Szabo, B. (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation, British Journal of Pharmacology, 126, 457-466.
69. Niederhoffer, N., Hansen, H. H., Fernandez-Ruiz, J. J. & Szabo, B. (2001). Effects of cannabinoids on adrenaline release from adrenal medullary cells, British Journal of Pharmacology, 134, 1319-1327.
70. Niederhoffer, N., Schmid, K. & Szabo, B. (2003) The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn-Schmiedeberg's Archives of Pharmacology, 367, 434-443.
71. Nogueron, M. I., Porgilsson, B., Schneider, W. E., Stucky, C. L. & Hillard, C. J. (2001). Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. Journal of Neurochemistry 79, 371-381.
72. Ohno-Shosaku, T., Maejima, T. & Kano, M. (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals, Neuron, 29, 729-738.
73. 3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus, European Journal of Neuroscience, 18, 109-116.
74. 1 cannabinoid receptor in primate brain, Neuroscience, 92, 1177-1191.
75. Pertwee, R. G. (1999). Pharmacology of cannabinoid receptor ligands, Current Medicinal Chemistry, 6, 635-664.
76. 1 receptors in mouse urinary bladder. British Journal of Pharmacology, 118, 2053-2058.
77. Pertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R. & Corbett, A. D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine, British Journal of Pharmacology, 105, 980-984.
78. Piomelli, D., Giuffrida, A., Calignano, A. & de Fonseca, F. R. (2000). The endocannabinoid system as a target for therapeutic drugs, Trends in Pharmacological Sciences, 21, 218-224.
79. Porter, A. C. & Felder, C. C. (2001). The endocannabinoid nervous system: unique opportunities for therapeutic intervention, Pharmacology & Therapeutics, 90, 45-60.
80. Ralevic, V. & Kendall, D. A. (2002). Cannabinoids inhibit pre- and postjunctionally sympathetic neurotransmission in rat mesenteric arteries, European Journal of Pharmacology, 444, 171-181.
81. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J. C. & Le Fur, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Letters, 350, 240-244.
82. 2 cannabinoid receptor. Journal of Pharmacology and Experimental Therapeutics, 284, 644-650.
83. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J. & Manzoni, O. J. (2001). Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. Journal of Neuroscience, 21, 109-116.
84. 2 cannabinoid receptors of L759633, L759656 and AM630, British Journal of Pharmacology, 126, 665-672.
85. Schlicker, E. & Kathmann, M. (2001). Modulation of transmitter release via presynaptic cannabinoid receptors, Trends in Pharmacological Science, 22, 565-572.
86. Schlicker, E., Timm, J. & Göthert, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina, Naunyn-Schmiedeberg's Archives of Pharmacology, 354, 791-795.
87. 1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release, British Journal of Pharmacology, 140, 323-328.
88. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus, Naunyn-Schmiedeberg's Archives of Pharmacology, 356, 583-589.
89. + M-current in hippocampal CA1 neurons. Journal of Neuroscience, 20, 51-58.
90. Shen, M., Piser, T. M., Seybold, V. S. & Thayer, S. A. (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. Journal of Neuroscience, 16, 4322-4334.
91. 1 receptors: Evidence for an endocannabinoid tone in the human neocortex, Neuroscience, 120, 455-465.
92. Sullivan, J. M. (1999). Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. Journal of Neurophysiology, 82, 1286-1294.
93. Szabo, B., Dörner, L., Pfreundtner, C., Nörenberg, W. & Starke, K. (1998). Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum, Neuroscience, 85, 395-403.
94. Szabo, B., Müller, T. & Koch, H. (1999). Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. Journal of Neurochemistry, 73, 1084-1089.
95. Szabo, B., Wallmichrath, I., Mathonia, P. & Pfreundtner, C. (2000). Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata, Neuroscience, 97, 89-97.
96. Szabo, B., Nordheim, U. & Niederhoffer, N. (2001). Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart. Journal of Pharmacology and Experimental Therapeutics, 297, 819-826.
97. Szabo, B., Siemes, S. & Wallmichrath, I. (2002). Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids, European Journal of Neuroscience, 15, 2057-2061.
98. Szabo, B., Than, M., Wallmichrath, I. & Thorn, D. (2004). Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat., Journal of Pharmacology and Experimental Therapeutics (im Druck).
99. 1 and CB, disrupts G-protein coupling, Journal of Pharmacology and Experimental Therapeutics, 285, 651-658.
100. Thompson, S. M., Capogna, M. & Scanziani, M. (1993). Presynaptic inhibition in the hippocampus. Trends in Neuroscience, 16, 222-227.
101. 1 receptors in the rat central nervous system, Neuroscience, 83, 393-411.
102. Twitchell, W., Brown, S. & Mackie, K. (1997). Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons, J. Neurophysiol., 78, 43-50.
103. Varma, N., Carlson, G. C., Ledent, C. & Alger, B. E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. Journal of Neuroscience, 21, RC188 (1-5).
104. Vaughan, C. W., McGregor, I. S. & Christie, McD. J. (1999). Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro, British Journal of Pharmacology, 127, 935-940.
105. Vaughan, C. W., Connor, M., Bagley, E. E. & Christie, McD. J. (2000). Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro, Molecular Pharmacology, 57, 288-295.
106. Wallmichrath, I. & Szabo, B. (2002a). Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata, Naunyn-Schmiedeberg's Archives of Pharmacology, 365, 326-334.
107. Wallmichrath, I. & Szabo, B. (2002b). Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse, Neuroscience, 113, 671-682.
108. Wilson, R. I. & Nicoll, R. A. (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses, Nature, 410, 588-592.
109. Wilson, R. I. & Nicoll, R. A. (2002). Endocannabinoid signaling in the brain, Science, 296, 678-682.
110. Wu, L.-G. & Saggau, P. (1997). Presynaptic inhibition of elicited neurotransmitter release. Trends in Neuroscience, 20, 204-212.
111. 1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. Journal of Neuroscience, 22, 1690-1697.
112. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D. & Hogestatt, E. D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide, Nature, 400, 452-457.